NCT05586672View on ClinicalTrials.gov

HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2028

Conditions
Autism Spectrum DisorderLanguage DevelopmentNeurocognitive DisordersChild Language
Interventions
DEVICE

EEG-HR

Passation EEG-HR

DIAGNOSTIC_TEST

ADI-R

Passation of ADI-R scale

DIAGNOSTIC_TEST

ADOS-2

Passation of ADOS-2 scale

DIAGNOSTIC_TEST

IDE

Passation of IDE scale

DIAGNOSTIC_TEST

MSEL

Passation of MSEL scale

DIAGNOSTIC_TEST

Dunn

Passation of Dunn scale

Trial Locations (1)

91150

Etablissement Public de Santé Barthélemy Durand, Étampes

All Listed Sponsors
lead

Etablissement Public de Santé Barthélemy Durand

OTHER

NCT05586672 - HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD | Biotech Hunter | Biotech Hunter